HSR21-061: Frequency of Oncologists (ONC) Office Visit and Caregiver Burden With Poly(ADP-ribose) Polymerase Inhibitor (PARPi) Versus Chemotherapy (CTX) Among Adult Patients (pts) With Germline BRCA1/2 Mutated (gBRCA1/2mut) HER2- Advanced Breast Cancer (ABC): Results From a Multi-Country Real-World (RW) Study

Authors:
Michael Lux Kooperatives Brustzentrum Paderborn; Frauenklinik St. Louise, Paderborn; St. Josefs-Krankenhaus, Salzkotten; and Frauen- und Kinderklinik St. Louise, Paderborn, Germany

Search for other papers by Michael Lux in
Current site
Google Scholar
PubMed
Close
 Prof, Dr, med, MBA
,
Alex Niyazov Pfizer Inc., New York, NY

Search for other papers by Alex Niyazov in
Current site
Google Scholar
PubMed
Close
 PharmD, MPH
,
Katie Lewis Adelphi Real World, Bollington, UK

Search for other papers by Katie Lewis in
Current site
Google Scholar
PubMed
Close
 BSc
,
Lucy Massey Adelphi Real World, Bollington, UK

Search for other papers by Lucy Massey in
Current site
Google Scholar
PubMed
Close
 BSc
,
Alex Rider Adelphi Real World, Bollington, UK

Search for other papers by Alex Rider in
Current site
Google Scholar
PubMed
Close
 BSc
,
Bhakti Arondekar Pfizer Inc., Collegeville, PA

Search for other papers by Bhakti Arondekar in
Current site
Google Scholar
PubMed
Close
 PhD, MBA
, and
Reshma Mahtani Sylvester Cancer Center, University of Miami, Deerfield Beach, FL

Search for other papers by Reshma Mahtani in
Current site
Google Scholar
PubMed
Close
 DO
Restricted access

Corresponding Author: Katie Lewis, BSc
  • Collapse
  • Expand

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 850 253 93
PDF Downloads 178 0 0
EPUB Downloads 0 0 0